| 1 |
Contribution of de novo and mosaic<i>TP53</i>mutations to Li-Fraumeni syndrome. ( 29070607
)
|
Renaux-Petel M....Bougeard G.
|
2018 |
| 2 |
Screening with whole-body magnetic resonance imaging in pediatric subjects with Li-Fraumeni syndrome: A single institution pilot study. ( 29077256
)
|
O'Neill A.F....Diller L.
|
2018 |
| 3 |
The first two confirmed sub-Saharan African families with germline TP53 mutations causing Li-Fraumeni syndrome. ( 29392648
)
|
Macaulay S....Krause A.
|
2018 |
| 4 |
Surveillance Screening in Li-Fraumeni Syndrome: Raising Awareness of False Positives. ( 29946497
)
|
Kumar P....Nicolaides T.
|
2018 |
| 5 |
Misdiagnosis of Li-Fraumeni Syndrome in a Patient With Clonal Hematopoiesis and a Somatic <i>TP53</i> Mutation. ( 29752319
)
|
Mitchell R.L....Usha L.
|
2018 |
| 6 |
Li-Fraumeni Syndrome-Related Malignancies Involving the Genitourinary Tract: Review of a Single-Institution Experience. ( 29935265
)
|
Murray K.S....Eastham J.A.
|
2018 |
| 7 |
What Should a Gynecologist Know about Li-Fraumeni Syndrome? Lessons from a Patient Undergoing Hysterectomy for Benign Indications. ( 29945152
)
|
Advolodkina P....Gordon A.N.
|
2018 |
| 8 |
Association Between the Oligomeric Status of p53 and Clinical Outcomes in Li-Fraumeni Syndrome. ( 29955864
)
|
Fischer N.W....GariAcpy J.
|
2018 |
| 9 |
Two cancer-predisposing variants in one family: Incidental finding of a fumarate hydrogenase (FH) germline variant in a family with Li-Fraumeni syndrome. ( 29893455
)
|
Pahl L....Steinemann D.
|
2018 |
| 10 |
A novel dysfunctional germline P53 mutation identified in a family with Li-Fraumeni syndrome. ( 29416929
)
|
Ji M....Yang K.
|
2018 |
| 11 |
Revisiting tumor patterns and penetrance in germline TP53 mutation carriers: temporal phases of Li-Fraumeni syndrome. ( 29076966
)
|
Amadou A....Hainaut P.
|
2018 |
| 12 |
Radiation-associated Angiosarcoma Mimicking Fallopian Tube High-grade Serous Carcinoma in a Woman With De Novo Li-Fraumeni Syndrome. ( 29620582
)
|
Crafton S.M....Suarez A.A.
|
2018 |
| 13 |
Successful Treatment of Recurrent Li-Fraumeni Syndrome-related Choroid Plexus Carcinoma. ( 28859040
)
|
McEvoy M....Green A.L.
|
2017 |
| 14 |
Colon Pathology Characteristics in Li-Fraumeni Syndrome. ( 28624650
)
|
Rengifo-Cam W....Kohlmann W.
|
2017 |
| 15 |
A novel TP53 germline inframe deletion identified in a Spanish series of Li-fraumeni syndrome suspected families. ( 28573494
)
|
Llovet P....GarcA-a-BarberA!n V.
|
2017 |
| 16 |
Autism spectrum disorder and Li-Fraumeni syndrome: purely coincidental or mechanistically associated? ( 28983852
)
|
Kuhlen M....Borkhardt A.
|
2017 |
| 17 |
Pleomorphic myxoid liposarcoma in an adolescent with Li-Fraumeni syndrome. ( 28160093
)
|
Sinclair T.J....Chao S.D.
|
2017 |
| 18 |
Inhibiting mitochondrial respiration prevents cancer in a mouse model of Li-Fraumeni syndrome. ( 27869650
)
|
Wang P.Y....Hwang P.M.
|
2017 |
| 19 |
Association of Li-Fraumeni Syndrome With Small Cell Carcinoma of the Ovary, Hypercalcemic Type and Concurrent Pleomorphic Liposarcoma of the Cervix. ( 28177947
)
|
Tandon B....Al-Kateb H.
|
2017 |
| 20 |
Familial Melanoma Associated with Li-Fraumeni Syndrome and Atypical Mole Syndrome: Total-body Digital Photography, Dermoscopy and Confocal Microscopy. ( 28218344
)
|
Giavedoni P....Malvehy J.
|
2017 |
| 21 |
Prevalence of Cancer at Baseline Screening in the National Cancer Institute Li-Fraumeni Syndrome Cohort. ( 28772286
)
|
Mai P.L....Savage S.A.
|
2017 |
| 22 |
Inherited TP53 Mutations and the Li-Fraumeni Syndrome. ( 28270529
)
|
Guha T....Malkin D.
|
2017 |
| 23 |
Breast cancer in patients with Li-Fraumeni syndrome - a case-series study and review of literature. ( 28356770
)
|
Nandikolla A.G....Anampa J.
|
2017 |
| 24 |
Li-Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53. ( 28818333
)
|
Zhou R....Lee D.F.
|
2017 |
| 25 |
Allele-specific wild-type TP53 expression in the unaffected carrier parent of children with Li-Fraumeni syndrome. ( 28279309
)
|
Buzby J.S....Nugent D.J.
|
2017 |
| 26 |
Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome. ( 28572266
)
|
Kratz C.P....Malkin D.
|
2017 |
| 27 |
Cancer Screening in Li-Fraumeni Syndrome. ( 28772307
)
|
Asdahl P.H....Hasle H.
|
2017 |
| 28 |
The psychosocial effects of the Li-Fraumeni Education and Early Detection (LEAD) program on individuals with Li-Fraumeni syndrome. ( 28301458
)
|
Ross J....Strong L.
|
2017 |
| 29 |
Frequency of Thyroid Carcinoma in Brazilian TP53 p.R337H Carriers With Li Fraumeni Syndrome. ( 28114597
)
|
Formiga M.N....Achatz M.I.
|
2017 |
| 30 |
Surveillance of Dutch Patients With Li-Fraumeni Syndrome: The LiFe-Guard Study. ( 28772294
)
|
Ruijs M.W.G....Sonke G.S.
|
2017 |
| 31 |
Nodular Lymphocyte-predominant Hodgkin Lymphoma in a 15-Year-Old Boy With Li-Fraumeni Syndrome Having a Germline TP53 D49H Mutation. ( 28902083
)
|
Yamazaki F....Shimada H.
|
2017 |
| 32 |
Li-Fraumeni syndrome presenting as mucosal melanoma: Case report and treatment considerations. ( 27726232
)
|
Klein J.D....Kupferman M.E.
|
2017 |
| 33 |
Estimating TP53 Mutation Carrier Probability in Families with Li-Fraumeni Syndrome Using LFSPRO. ( 28137790
)
|
Peng G....Wang W.
|
2017 |
| 34 |
Li-Fraumeni versus Pseudo-Li-Fraumeni Syndrome: Key Insights for Interpreting Next-Generation Sequencing Reports in Patients with Suspected Cancer Predisposition Syndromes. ( 28592622
)
|
Sorscher S....Ramkissoon S.
|
2017 |
| 35 |
Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis. ( 28772291
)
|
Ballinger M.L....Savage S.A.
|
2017 |
| 36 |
Primary Cutaneous Leiomyosarcoma Arising in a Patient With Li-Fraumeni Syndrome. A Neoplasm With Unusual Histopathologic Features and Loss of Heterozygosity at TP53 Gene. ( 28475508
)
|
Sabater-Marco V....LA^pez-Guerrero J.A.
|
2017 |
| 37 |
Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) clinic. ( 28988289
)
|
Bojadzieva J....Strong L.C.
|
2017 |
| 38 |
Lung Adenocarcinoma as Part of the Li-Fraumeni Syndrome Spectrum: Preliminary Data of the LIFSCREEN Randomized Clinical Trial. ( 28772306
)
|
Caron O....BrugiA"res L.
|
2017 |
| 39 |
Is Li-Fraumeni syndrome really much more common? ( 29091331
)
|
Thomas D.M.
|
2017 |
| 40 |
Increasing genomic instability during cancer therapy in a patient with Li-Fraumeni syndrome. ( 29594232
)
|
Schuler N....RA1be C.E.
|
2017 |
| 41 |
Should Genetic Testing be Offered for Children? The Perspectives of Adolescents and Emerging Adults in Families with Li-Fraumeni Syndrome. ( 28303452
)
|
Alderfer M.A....Nichols K.E.
|
2017 |
| 42 |
The Features of Colorectal Tumors in a Patient with Li-Fraumeni Syndrome. ( 28154273
)
|
Yoshida T....Niwa Y.
|
2017 |
| 43 |
Atypical cutaneous melanocytic tumours arising in two patients with Li-Fraumeni syndrome. ( 29108654
)
|
Jacquemus J....de la FouchardiA"re A.
|
2017 |
| 44 |
Hsp90 and PKM2 Drive the Expression of Aromatase in Li-Fraumeni Syndrome Breast Adipose Stromal Cells. ( 27467582
)
|
Subbaramaiah K....Dannenberg A.J.
|
2016 |
| 45 |
Genetic and functional analysis of a Li Fraumeni syndrome family in China. ( 26818906
)
|
Hu H....Li J.D.
|
2016 |
| 46 |
Super-Transactivation TP53 Variant in the Germline of a Family with Li-Fraumeni Syndrome. ( 27297285
)
|
Id Said B....Malkin D.
|
2016 |
| 47 |
Multiple primary tumors in a family with Li-Fraumeni syndrome with a TP53 germline mutation identified by next-generation sequencing. ( 27516001
)
|
Zampiga V....Calistri D.
|
2016 |
| 48 |
Does PTEN gene mutation play any role in Li-Fraumeni syndrome. ( 27493922
)
|
Akouchekian M....Dehghan Manshadi M.
|
2016 |
| 49 |
Rare germline variant (rs78378222) in the TP53 3' UTR: Evidence for a new mechanism of cancer predisposition in Li-Fraumeni syndrome. ( 26823150
)
|
Macedo G.S....Ashton-Prolla P.
|
2016 |
| 50 |
Biochemical and imaging surveillance in Li-Fraumeni syndrome - Authors' reply. ( 27819240
)
|
Villani A....Malkin D.
|
2016 |
